A vaccine against cancer is not as far-fetched as it might sound, as a team of scientists from the Dr. Rath Research Institute in California has already developed a peptide-based vaccine that is effective in reducing tumor growth. The vaccine targets specific enzymes known as metalloproteinases (MMPs) that are necessary for any cancer to grow tumors, metastasize, and form blood vessels in tumors (angiogenesis).
When animals were vaccinated with peptides and then challenged with melanoma cancer cells, the scientists found they had an average reduction in tumor volume of about 76 percent compared to unvaccinated animals. Particularly notably, some of the vaccinated animals didn’t develop any cancer at all.
Based on this research, the Dr. Rath Research Institute believes that peptide vaccines have the potential to help prevent cancer, thereby saving millions of lives and opening the door to the eventual elimination of this disease.
To learn more about the Dr. Rath Research Institute’s development of a peptide-based cancer vaccine, see this press release on our website.
New Research Suggests Boosting Potassium is Key For Blood Pressure Control
February 29, 2024Africa’s Latest Cholera Outbreaks: As Vaccine Stocks Run Out, It’s Time To Consider Alternatives
March 1, 2024Russia on Verge of Creating Cancer Vaccines, Putin Claims
News
President Vladimir Putin recently announced that Russian scientists were on the cusp of developing a vaccine for cancer, adding that he hopes the new therapy could be applied to individual treatments in the future.
[Source: americanmilitarynews.com]
[Image source: Adobe Stock]
Comment
A vaccine against cancer is not as far-fetched as it might sound, as a team of scientists from the Dr. Rath Research Institute in California has already developed a peptide-based vaccine that is effective in reducing tumor growth. The vaccine targets specific enzymes known as metalloproteinases (MMPs) that are necessary for any cancer to grow tumors, metastasize, and form blood vessels in tumors (angiogenesis).
When animals were vaccinated with peptides and then challenged with melanoma cancer cells, the scientists found they had an average reduction in tumor volume of about 76 percent compared to unvaccinated animals. Particularly notably, some of the vaccinated animals didn’t develop any cancer at all.
Based on this research, the Dr. Rath Research Institute believes that peptide vaccines have the potential to help prevent cancer, thereby saving millions of lives and opening the door to the eventual elimination of this disease.
To learn more about the Dr. Rath Research Institute’s development of a peptide-based cancer vaccine, see this press release on our website.
Dr. Rath Health Foundation
Related posts
Research Suggests Probiotics Plus Vitamin D Supplements May Benefit People With Schizophrenia
Read more